Article Figures & Data
Figures
- fig 1.
A, Surgical risk versus cost (adjusted for cost of embolization). Spetzler-Martin grades V and IV differed from all other grades (P < .005 and P < .05, respectively).
B, Surgical risk versus days in the hospital (adjusted for effect of embolization). Spetzler-Martin grades V and IV differed from grades III and II (P < .005 and P < .05, respectively).
All values shown as mean ± SEM.
- fig 2.
A, Postoperative neurologic status versus cost (adjusted for preoperative embolization). Difference in cost was significant (P = .016).
B, Postoperative neurologic status versus days in hospital (adjusted for preoperative embolization). Difference in length of stay was significant (P = .008).
All values shown as mean ± SEM.
Tables
- TABLE 2:
Distribution of Spetzler-Martin scores for patients who only had surgery, those who had embolization and surgery, and all patients combined
- TABLE 3:
Total cost and days in hospital by surgical risk category and use of preoperative embolization
In this issue
Jump to section
Related Articles
Cited By...
- Viewpoints on the ARUBA Trial
- Hull Down on the Horizon: A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial
- International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
- The ARUBA Trial: Current Status, Future Hopes
- Economic Burden of Intracranial Vascular Malformations in Adults: Prospective Population-Based Study
- Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature
- Arteriovenous malformations of the brain: ready to randomise?
- Recommendations for the Management of Intracranial Arteriovenous Malformations : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Stroke Association
- Recommendations for the Management of Intracranial Arteriovenous Malformations : A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Stroke Association